Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
We have a wide range of fun and festive designs to choose from. Fund life changing research while spreading joy this Christmas!
This Christmas, your gift can bring us closer to a cure for type 1 diabetes – and every pound you give to our Christmas Appeal will be doubled.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This event is designed for anyone living with type 1 diabetes who would like to learn more about managing their wellbeing across a variety of contexts.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > Knowledge & support > Managing type 1 diabetes > Guide to type 1 diabetes technology > Hybrid closed loop technology (artificial pancreas) > Can I get hybrid closed loop technology on the NHS?
This page is a summary of what is available on the NHS. Talk to your Diabetes Healthcare Team about what is available to you and how it might help.
If you have any questions about or issues with accessing technology, contact us.
Hybrid closed loop is not yet widely available through the NHS in England and Wales. However, if you meet the criteria for an insulin pump then you can choose a pump that will form a hybrid closed loop with your choice of continuous glucose monitor (CGM).
If the CGM you’re already using doesn’t work with a pump to form a hybrid closed loop, then you will be able to change to a one that does (under the National Institute for Health and Care Excellence (NICE) guidelines).
Hybrid closed loop systems can also be purchased from manufacturers privately, depending on the level of support available to you through your healthcare provider. Talk to your healthcare team to find out more about the options available to you.
In 2022 NICE announced successful results for an artificial pancreas pilot and is expected to update its guidance on hybrid closed loop for England and Wales in 2023. We have given feedback on the draft recommendations to call for hybrid closed loop technology to be more widely available on the NHS.
Hybrid closed loop technology is not yet widely available through the NHS in Northern Ireland. This is because insulin pump therapy and CGM are not widely available. However, as flash glucose monitoring is more available, some people have built a DIY hybrid closed loop.
NHS Scotland has recommended that hybrid closed loop systems should be pro-actively discussed with all patients with type 1, particularly those who have:
It also recommended that people already using both a CGM and an insulin pump should be offered a closed-loop system, but if people are managing well with how they already manage their type 1, they should stay on that care plan.
Read the recommendations in full for more detail.
One of our main goals at JDRF is to make sure that everyone with type 1 diabetes who wants or needs a hybrid closed loop system is able to get one for free. Read more about our treatment advocacy work and how you can support us.
Learn about what technology is available to manage type 1 and how to access it.
Learn about hybrid closed loop technology (also known as the artificial pancreas) and how it can help you manage your type 1.
Draft guidance has been published to make hybrid closed loop more widely available.
Our international research programme means that life-changing treatments and developments for type 1 diabetes are in clinical trials around the world.